Throne Science’s $10M Raise Isn’t Just About Smart Toilets—It’s About Fixing Healthcare’s Data Problem

Wearables taught us that our hearts and sleep can be tracked passively. Now the same logic is creeping into the bathroom, and it’s about more than just wellness. Marlize van Romburgh at Crunchbase News broke the news that Throne Science, co-founded by former Whoop CTO John Capodilupo, just closed a $10 million Series A. The startup makes an AI-powered toilet camera that tracks gut health and hydration from what you leave behind. The pitch is compelling: passive, objective data on a bodily function that’s been notoriously hard to measure at scale.

But when I read about Throne, I don’t just see a better poop journal for biohackers. I see a potential fix for one of healthcare’s most stubborn and costly problems: the black hole of manual documentation.

At PainSignal, we track problems that healthcare workers complain about every day. Not sanitized surveys—real, raw frustrations from the front lines. We’ve logged 707 healthcare-related problems and generated 434 app ideas from them. A huge slice of those boil down to errors and inefficiencies caused by humans writing down or typing in data that machines should be capturing automatically. One problem we documented, MedLog Sync, involved a nurse placed on unpaid leave because of discrepancies between manually entered blood sugar records and the glucometer’s own audit trail. Severity: 5 out of 5. This isn’t just an annoyance—it’s a career-ending, patient-harming flaw in how we collect clinical data.

Throne’s core insight is that self-reported bowel habits are similarly unreliable. The Crunchbase piece notes that research studies often depend on patients “accurately describing and recording their own bathroom habits.” Anyone who’s ever filled out a food diary knows how that goes. Throne replaces that with passive computer vision. That’s neat for the quantified-self crowd, but it’s potentially transformative for clinical settings where what comes out of a patient is a critical vital sign.

Think about hospitals. We’ve seen problems like “Nurses lack real-time notification and escalation for critical blood pressure values” rated severity 5/5, and “ICU nurses risk medication errors when residual IV lines and pumps from previous procedures cause unintended drug administration”—also a 5/5. These aren’t hypotheticals. They’re daily realities that point to a systemic gap in real-time, automated physiological monitoring. Urine output, for example, is a key metric in acute care, often tracked manually on whiteboards. Throne’s technology isn’t just for stool—the article mentions it analyzes urine too. Adapt that into a clinical setting, and suddenly you’ve got a passive monitor that feeds objective data into existing hospital systems, reducing the cognitive load on nurses and slashing documentation errors.

Capodilupo, in the Crunchbase piece, says longitudinal data “is the whole game.” He’s right, but the consumer use case only scratches the surface. The really high-stakes longitudinal data lives in healthcare, where a missed change in output can mean a missed diagnosis or a fatal medication error. And that’s where the willingness to pay gets explicit—hospitals spend billions on EHRs and monitoring equipment, yet still rely on humans to eyeball and jot down basic outputs.

Throne is wise to explore sales through clinicians and functional-medicine practitioners, as the article mentions. But I’d bet the biggest untapped market is acute-care hospitals and long-term care facilities. We’re already seeing an explosion of app ideas around clinical documentation automation. Our data is flooded with them—tools like “DocuFlow Time Bridge” (severity 5/5) that aim to bridge the gap between what happens to a patient and what gets written down. Throne’s camera could become the data source that feeds those AI systems, making the entire loop passive and accurate.

The $10 million round, led by Will Ventures, is a solid bet on the wearable-to-wasteable transition. But the investor I’d want to talk to is the one who sees Throne not as a consumer gadget company but as a clinical monitoring platform in disguise. The Crunchbase article mentions a longer-term goal of a “smoke detector for colon cancer.” That’s a great vision, but there’s a nearer-term, high-severity problem right in front of us: hospital data capture is broken, and whatever fixes it gets paid.

Throne’s AI coach, currently in beta, is interesting but feels like a wedge. The real moat will come if they can get their data pipeline into the clinic. Our data suggests the demand is screaming for it: 707 healthcare problems, many with severity 5/5, tied to manual documentation and monitoring failures. The market isn’t just people who want to optimize their microbiome. It’s hospitals that can’t afford another $100,000 malpractice suit because a nurse wrote down the wrong urine output.

So while everyone else is talking about smart toilets, I’m watching for Throne’s first clinical pilot. That’s when this stops being a wellness toy and starts being infrastructure. And for investors, that’s when the real multiple kicks in.